← Back to headlines
Invivyd Stock Rises Following Positive Update from Late-Stage COVID Therapy Trial
Invivyd's stock saw an increase after the company provided an update on its late-stage clinical trial for a COVID-19 therapy.
9 Apr, 17:23 — 9 Apr, 17:23
Sources
Showing 1 of 1 sources
